missing translation for 'onlineSavingsMsg'
Learn More

Invitrogen™ D4-GDI Monoclonal Antibody (10D774)
GREENER_CHOICE

Mouse Monoclonal Antibody

Brand:  Invitrogen™ MA141181

Product Code. 11539812

  • £442.00 / 100µg

Please to purchase this item. Need a web account? Register with us today!

This item is not returnable. View return policy

Description

Description

Suggested positive control: antigen standard for ARHGDIB (transient overexpression lysate), Daudi or Jurkat.

Acts as a ventralizing factor during embryogenesis. Inhibits axin-mediated JNK activation by binding axin and disrupting axin homodimerization. This in turn antagonizes a Wnt/beta-catenin-independent dorsalization pathway activated by AXIN/JNK-signaling.
TRUSTED_SUSTAINABILITY
Specifications

Specifications

D4-GDI
Monoclonal
Unconjugated
ARHGDIB
ARHGDIB; D4; d4 gdi; GDI LYGDI; GDIA2; GDID4; LYGDI; Ly-GDI; RAP1GN1; Rho GDI 2; Rho GDP dissociation inhibitor (GDI) beta; Rho GDP dissociation inhibitor beta; rho GDP-dissociation inhibitor 2; Rho, GDP dissociation inhibitor (GDI) beta; rho-GDI beta; RhoGDI2
Mouse
Protein G
RUO
397
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Liquid
Flow Cytometry, Western Blot
10D774
PBS with 0.02% gelatin and 0.02% sodium azide
P52566
ARHGDIB
A synthetic peptide corresponding to human D4-GDI/RhoGDI2.
100 μg
Primary
Human
Antibody
IgG
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Certificates
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.